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A New Method for Preliminary Identification of
Gene Regulatory Networks from Gene Microarray
Cancer Data Using Ridge Partial Least Squares With
Recursive Feature Elimination and Novel Brier and
Occurrence Probability Measures
S. C. Chan, Member, IEEE, H. C. Wu, Student Member, IEEE, and K. M. Tsui
Abstract—This paper proposes a new method for preliminary
identification of gene regulatory networks (GRNs) from gene mi-
croarray cancer databased on ridge partial least squares (RPLS)
with recursive feature elimination (RFE) and novel Brier and
occurrence probability measures. It facilitates the preliminary
identification of meaningful pathways and genes for a specific
disease, rather than focusing on selecting a small set of genes for
classification purposes as in conventional studies. First, RFE and
a novel Brier error measure are incorporated in RPLS to reduce
the estimation variance using a two-nested cross validation (CV)
approach. Second, novel Brier and occurrence probability-based
measures are employed in ranking genes across different CV
subsamples. It helps to detect different GRNs from correlated
genes which consistently appear in the ranking lists. Therefore,
unlike most conventional approaches that emphasize the best
classification using a small gene set, the proposed approach is able
to simultaneously offer good classification accuracy and identify
a more comprehensive set of genes and their associated GRNs.
Experimental results on the analysis of three publicly available
cancer data sets, namely leukemia, colon, and prostate, show that
very stable gene sets from different but relevant GRNs can be iden-
tified, and most of them are found to be of biological significance
according to previous findings in biological experiments. These
suggest that the proposed approach may serve as a useful tool for
preliminary identification of genes and their associated GRNs of a
particular disease for further biological studies using microarray
or similar data.
Index Terms—Cancer classification, gene regulatory network
(GRN), logistic regression (LR), microarray data, novel Brier and
occurrence probability (OP) measures, ridge partial least squares
(RPLS) regression.
I. INTRODUCTION
THE STUDY of gene regulatory networks (GRNs) hasreceived considerable attention in systems biology be-
cause of its potential in explaining various biological processes.
Such information could be very useful to clinical applications,
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such as the prediction of cancer and other diseases, etc. Many
methods have been proposed for stability [1], modeling [2]–[6],
and inference [7], [8] of GRNs.
In this paper, we focus on the detection of statistically more
influential genes and utilize them for preliminary identification
of GRNs associated with specific cancer using gene microarray
data. A gene microarray sample consists of an observation (e.g.,
the subject with/without cancer for binary classification) and
a set of gene expression intensities. Due to the high cost of
obtaining the gene microarray data and the limited number of
patients, such microarray data usually contain small number
of samples but a large number of gene expressions. Therefore,
even the identification of a few marker genes presents great
challenges due to the curse of dimensionality and limited
samples.
Conventionally, gene identification is considered as a fea-
ture selection problem, and two well-known types of feature
selection algorithms are the filter-based and wrapper-based
algorithms. Typical filter-based algorithms rely on measures
such as the signal-to-noise ratio (SNR) [9], t-statistics (t-test)
[10], Fisher’s criterion (FC) [11], point biserial correlation co-
efficients (PC) [12], and so on to select the important genes, and
discard those with lower scores. One of the major drawbacks
of the filter-based algorithms is that the gene expressions are
assumed to be independent, but in practice, they are usually
correlated due to their pathway dependencies [13]. On the other
hand, many wrapper-based algorithms such as [14]–[17] have
been proposed for gene selection aiming at better classification
performance.
While most algorithms focus on identifying a small gene
set for the best classification performance, we take a different
approach in this paper to study the detection of a larger set of
cancer-related genes so as to preliminarily identify the GRNs
associated with the cancer. One of the major challenges on
identifying the GRNs is to tackle the pathway dependencies
among the genes. A master control gene, which is an active
gene at the top of a control hierarchy, usually shares a common
pathway with some amplifier genes that serve to amplify the
signal on the same GRN. When the master control gene is
expressed, it triggers the amplifier genes to amplify the signal
on the GRN, which might further trigger a cascade of other
1083-4427/$31.00 © 2012 IEEE
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TABLE I
TOP 3 RANKING GENES CHOSEN BY t-TEST METHOD FOR COLON DATA
GRNs and turn on a huge number of other genes [18]. An
illustrative example in [19] suggests that a single signal from a
master control gene can trigger the out-of-place eye production
in the fruit fly Drosophila. Therefore, the expression of the
genes on the same GRN are correlated, and a subtle change
in the expression of the master control gene may have strong
physiological consequence, while its change of expression
may be hidden by other related amplifier genes on the same
GRN [13].
Biological and statistical variability is another challenge for
the identification of GRNs and cancer-related genes. Conven-
tionally, there are two approaches in ranking genes in regression
techniques. The simplest one is to invoke the algorithm on
the whole data set, i.e., use the whole data set as training,
and select the subsets with the best performance. However,
due to small number of samples, the estimation is subject to
large variance though the classification accuracy on the samples
themselves may be high, i.e., it lacks generalization ability
due to overfitting. Another more reasonable approach reported
in [20] is to employ cross validation (CV) to evaluate the
performance of the classifier where the data are divided into
various training and testing sets. The training set is used to
determine the best classifier for a given gene set while the
testing set is used to evaluate their performances. Generally,
this gives better classification performance in practice, but the
computational time may be prohibited if one wishes to try every
single possible combination from the gene set. Moreover, the
direct interpretation of the gene ranking (GR) is difficult due
to the variation of GRs across different CV subsamples. As an
illustration, Table I shows the top three ranked genes which
are selected by t-test from different subsamples generated by
10− fold CV. It can be seen in Table I that the genes ranked
by the t-test method in general vary considerably across CV
subsamples.
To overcome these limitations, we propose in this paper
an approach based on the ridge partial least squares [21]
(RPLS) with recursive feature elimination (RFE), and novel
Brier and occurrence probability (OP) measures, or RPLS-RFE
method in short. The RPLS is commonly used in classification
problems, and it combines the ridge logistic regression (LR)
and the PLS [22] to reduce the large variance in estimation.
However, when it is applied to the detection of cancer-related
genes, one has to test all combinations according to certain
criteria, such as misclassification error derived from the RPLS.
Unfortunately, the complexity could be very high because the
total number of genes is generally large and the number of
cancer-related genes is unknown. Hence, an efficient approach
that can choose the desired genes systematically is required. A
possible candidate is the RFE, which is a backward elimination
procedure. In the context of microarray analysis, it can be used
to efficiently remove genes with least contribution to a classifier
and to reduce the computational time for model selection to an
acceptable level.
The proposed method possesses three distinct and desirable
features.
1) It employs the RPLS method so that the correlation be-
tween the genes from different networks can be taken into
account. Consequently, it is able to explore the pathway
dependencies of the genes involved. Together with the
RFE, the variance of the regression coefficients can be
significantly reduced, while considerably reducing the
computational time in finding the relevant genes.
2) Novel Brier measure: Although combining RPLS and
RFE helps to extract the correlation among the genes,
it is still insufficient to detect significant genes for the
identification of GRNs. In conventional RFE, misclassi-
fication error is often employed as a selection criterion
for classification problem. However, such hard decision
metric is not a good choice for our purpose because
some useful information regarding the gene-gene corre-
lation may be lost due to the quantization of the metric.
Therefore, we proposed to employ the Brier score (BS)
which is a soft decision metric. The advantage of the
BS is that it is continuous, and hence it is less prone
to quantization effect of conventional misclassification
error and provides a more accurate estimation of the
prediction model. Though RPLS has been reported before
for classification, the incorporation of RFE with Brier
error measure and its application to preliminary GRN
identification is to our best knowledge new.
3) Novel OP measure: As mentioned earlier, although the
conventional CV approach was proved to improve clas-
sification performance in many studies that focus on
classification, the extracted GRs are generally not consis-
tent say for different portion of data samples as shown
in Table I. Hence, we adopt the recent two-nested CV
procedure to randomly partition data samples in order to
explore the variations of the genes chosen by the RPLS-
RFE algorithm on different portions of data samples.
Another advantage of the two-nested CV procedure is
that it avoids the problem of overfitting (also known as
selection bias) when using the same CV loop for both
parameter tuning and performance evaluation [23]. More-
over, we propose a new measure called the OP, which
counts the occurrence of a given gene on the chosen gene
sets across different CV subsamples. This provides a very
effective criterion for selecting correlated genes with po-
tentially biological significance, rather than just reducing
the size of the gene sets to boost the recognition rate
using different gene sets. It is an important advantage that
allows us to detect different GRNs from the correlated
genes, which consistently appear in the ranking lists of
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the CV subsamples through public domain gene network
database.
By combining the good performance of the proposed RPLS-
RFE method and the novel Brier and OP-based measures, it will
be shown later by our experimental results on three publicly
available cancer data sets namely, the leukemia [9], colon [24],
and prostate [25], that very stable gene sets from different
but relevant GRNs can be identified using a two-nested CV
procedure. Moreover, most of them are found to be of biolog-
ical significance after carefully checking with related literature
based on biological experiments. To further substantiate the
statistical significance of the extracted gene sets, a model that
assumes all the genes are solely picked by random is used to
show that these gene sets appearing in the multiple CV trials is
not a result of statistical variation. More precisely, 43, 40, and
38 out of 50 extracted genes using the proposed OP criterion
for the leukemia, colon, and prostate data sets, respectively,
are found to be significant at 5% significance level, which
is similar in spirit to the commonly used p-value. This pro-
vides strong statistical significance of the gene sets extracted.
Furthermore, almost all of these genes and GRNs cannot be
revealed by conventional methods which focus mainly on the
classification performance. These findings suggest that the pro-
posed method is capable of detecting preliminarily genes and
associated GRNs from the microarray cancer data, which may
serve as a useful tool for preliminary detection of genes and
their associated GRNs associated with a particular disease from
microarray or similar data for further biological studies. Finally,
it should be noted that the present work is different from the
gene network identification from time course gene microarray
data, which may allow one to study the detailed regulatory
mechanism of the networks. The main objective of this work is
to employ “one-time point” labeled microarray data to identify
stable gene sets which may be related to a given disease with
high statistical significance, so called “targets,” and to perform
preliminary identification of GRNs or pathways with the aid
of public domain gene network database. The ultimate goal is
to conduct detailed biological experiments on these targets to
reveal more clearly the underlying regulatory mechanism.
The paper is organized as follows. Previous works on gene
identification are briefly reviewed in Section II. Section III
is devoted to the proposed method. In Section IV, we pro-
vide a comprehensive evaluation of the proposed method with
other conventional algorithms and demonstrate new results
on preliminary identification of cancer-related genes and their
associated GRNs. Finally, conclusion is drawn in Section V.
II. PREVIOUS WORKS
A microarray sample consists of gene expression intensities
collected for a large number of genes and its associated class
label or observation, which can be binary or multiclass. In
this paper, we focus on the analysis of commonly encoun-
tered two-class microarray data. More specifically, consider
an observation y = 0, 1, which depends on the expressions
of J genes of a subject given by an (J × 1) variable vector
x = [x1, x2, . . . , xJ ]
T
, where the superscript T denotes matrix
transpose. Usually, due to large dynamic range of gene expres-
sions, data preprocessing such as logarithmic transformation
will be performed on x.
Suppose further that we have the gene expressions and
the associated labels of N subjects or samples. Then, the
N observations of y and its corresponding gene expressions
can be grouped into an (N × 1) vector Y = [y1, y2, . . . , yN ]T
and a (N × J) matrix X = [x1,x2, . . . ,xN ]T , respectively,
where xi = [xi,1, xi,2, . . . , xi,J ]T , i = 1, . . . , N , are the gene
expressions of the ith subject. Moreover, X is centered and
standardized as
xi,j =
(xi,j − μj)
σj
(1)
where μj = 1NΣ
N
i=1xi,j and σj are, respectively, the mean and
standard deviation of the jth gene expression given by
σj =
√√√√ 1
N − 1
N∑
i=1
(xi,j − μj)2. (2)
For the sake of presentation, we denote X as the gene expres-
sion matrix after centering and standardization, and its (i, j)
entry is given by (1).
In the filter-based approach, the ranking of a gene is deter-
mined independently by calculating the discrimination power
of each gene according to certain measure and sorting them
in a descending order. Four of the most commonly used filter
approaches for gene selection are S2N, t-test, PC, and FC. In
these methods, the gene expression matrix X is further divided
into two subclasses X− and X+ for class 0 and class 1, i.e.,
the samples with label y = 0 and y = 1, respectively. The S2N
method measures the mean separation of the two classes for a
particular gene with respect to their spread as follows:
SNR(j) =
∣∣μ−j − μ+j ∣∣(
σ−j + σ
+
j
) (3)
where μ−j and σ−j (μ+j , and σ+j ) are, respectively, the mean and
standard deviation of the jth gene expression of X−(X+). The
t-test method further takes the number of samples in each class
into account in computing the spread
T (j) =
∣∣μ+j − μ−j ∣∣√(
σ+j
)2
/N+ − (σ−j )2 /N−
(4)
where N− and N+ are the total number of samples in classes 0
and 1, respectively. The PC method uses a similar but different
weighting as follows:
PC(j) =
(
μ+j − μ−j
)
√[
N
N+N−
]∑N
i=1(xi,j − μj)2
. (5)
On the other hand, the FC method measures the normalized
Euclidean distance between the centers of the two classes as
fc(j) =
(
μ+j − μ−j
)2
((
σ+j
)2
+
(
σ−j
)2) . (6)
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The identification of relevant genes for a particular disease from
labeled gene microarray data is then performed by ranking the
genes according to the scores produced by one or more of these
measures. After that, a subset of sJ , 0 ≤ s  1, ranked gene
indices, Ssub, in descending order is obtained
Ssub = {1 ≤ j ≤ J : |d(j)| is the first sJ largest of all}
(7)
where . is the ceiling operator, and d(j) can be either
SNR(j), T (j), fc(j), PC(j), or some combinations of them.
The parameter s is usually chosen as a value much smaller
than 1 to retain a small subset of sorted genes. Generally, these
selected genes in Ssub are considered to be more statistically
significant and they are retained for classification or further
studies. However, a major drawback of the filter approach is
that the correlation between the genes is ignored, and hence
some biological significant genes may be rejected.
In the wrapper-based approach, classification accuracy is
used as the scoring metric to grade the relevance of the chosen
genes. First, a search algorithm is used to search through
the space of possible subset of genes. Then, the classifier is
invoked to evaluate the classification accuracy of the chosen
subset. Consequently, the subset of genes that gives the best
classification accuracy is retained for classification.
Motivated by the simplicity of the filter-based approach and
the good classification accuracy of the wrapper-based approach,
a hybrid approach was proposed in [16]. A filter algorithm
is first invoked on the whole set of genes to retain only a
small subset of relevant genes. Then, the wrapper algorithm is
invoked on the retained gene subset of a much smaller size.
Hence, the computation speed of the wrapper algorithm can
be further improved. In particular, a multiple-filter-multiple-
wrapper algorithm was proposed in [17], which combines the
use of different filter metrics so that more relevant genes are
retained. Moreover, multiple wrappers are used to choose the
genes according to a consensus established among several
classifiers. Hence, the identified genes generally have a mixture
of characteristics that gives good classification accuracy for the
included classifiers.
However, the selection process in the aforementioned ap-
proaches either do not take into account correlation of genes
or focusing only on a few key genes for classification purpose.
Therefore, they may not able to identify relevant genes from
different GRNs. Next, we will present the proposed approach
which aims at identifying a more comprehensive set of genes
from different GRNs, without scarifying the classification per-
formance. These genes can serve as potential targets for in-
vestigating more detailed regulatory actions between the GRNs
using biological experiments and time course data.
III. PROPOSED APPROACH
The proposed approach can be summarized as follows: First,
a two-nested CV procedure is used to divide the data set
into subsamples for training and testing. An advantage of the
two-nested CV procedure is that it avoids the selection and
optimization bias found in the conventional CV procedure [20],
[23]. Second, the RPLS and the RFE algorithms are invoked
recursively so as to eliminate irrelevant genes from the selected
TABLE II
PROPOSED RPLS-RFE APPROACH
gene subsets using the BS. Finally, the proposed OP-based mea-
sure is used to rank the genes obtained across different CV sub-
samples. Table II summarizes the key implementation steps of
the proposed method. For better exposition and understanding
of the RPLS algorithm, it is summarized in Section III-A below.
A. Ridge Partial Least Squares
The RPLS method [21] combines PLS with LR and ridge
regression to reduce the variance of the regression estimate.
LR is a type of generalized linear model used for binary
regression. It only relies on the conditional class probability
P (y|x), or equivalently the conditional expectation of Y given
1518 IEEE TRANSACTIONS ON SYSTEMS, MAN, AND CYBERNETICS—PART A: SYSTEMS AND HUMANS, VOL. 42, NO. 6, NOVEMBER 2012
x, and so it does not require the usual normal assumption on
the distribution. This makes it less sensitive to model mis-
specification [26]. On the other hand, PLS is an efficient di-
mensional reduction technique which can be applied to LR to
reduce the large variance resulting from the high dimension and
small number of samples problem. In RPLS, ridge regression
is further employed with PLS to reduce the variance of the
estimates.
More precisely, for binary regression, LR models the con-
ditional class probability P (y = 1|x) for x in class 1 as the
following function of the explanatory variables x:
P (y = 1|x) = e
η(α,β,x)
1 + eη(α,β,x)
= h (η(α,β,x)) = p(α,β,x)
(8)
where the link function of the GLM, h(η), is chosen as the
logistic function eη/(1 + eη) and η(α,β,x) is chosen as a
linear predictor in terms of x with regression coefficients β =
[β1, β2, . . . , βJ ]
T and intercept α
η(α,β,x) = α+ xTβ. (9)
Using (8) and (9), one can verify that ln(P (y = 1|x))−
ln(1− P (y = 1|x) = α+ βTx. Since it is a binary
regression, 1− P (y = 1|x) represents the conditional
class probability for x to be in class 0. The unknown
parameters α and β are usually estimated by maximum
likelihood method, which can be computed numerically
by using the iteratively reweighted least squares (IRWLS)
method. More precisely, given the observations Y TRAIN
and processed input gene expression matrix XTRAIN of
a training set STRAIN , the likelihood function can be
written as L(α,β|STRAIN ) =
∏NTRAIN
i=1 P (α,β|xi, yi) =∏NTRAIN
i=1 (p(α,β,xi))
yi(1− p(α,β,xi))1−yi , where
NTRAIN is the number of training samples, and we have
assumed that the samples are independent. The regression
coefficients can be estimated by maximizing the likelihood
function or equivalently the log-likelihood function as follows:
ln(L) =
N ′∑
i=1
[yi ln pi(α,β) + (1− yi) ln (1− pi(α,β))]
(10)
where for notation convenience, we have used pi(α,β) for
p(α,β,xi), ln(L) for lnL(α,β|STRAIN ), N ′ for NTRAIN
and Y for Y TRAIN . To simplify notation, we further define
X˜ = [1N ′ XTRAIN ] and γ = [α βT ]
T
. (11)
where 1N denotes an (N × 1) vector with all entries equal
to ones. As shown in Appendix A, the desired solution of
maximizing the log-likelihood in (10) satisfies
(X˜
T
W˜ X˜)γ ≈ X˜T (Y − p˜+ W˜ X˜γ˜) (12)
where W˜ = diag{w˜1, w˜2 . . . .w˜N ′}, w˜i = p˜i(1− p˜i), and
p˜i = pi(γ˜) = pi(α˜, β˜). By solving (12) and using the solution
as the new estimate γ˜ = [α˜ β˜T ]
T
repeatedly, one obtains the
IRWLS algorithm for solving the regression coefficients. Usu-
ally, the iteration stops when a maximum number of iterations
is reached or when the change in successive γ˜’s is sufficiently
small. From (12), one can also notice that
(X˜
T
W˜ )X˜γ≈(X˜TW˜ )
(
W˜
−1
(Y −p˜)+X˜γ˜
)
=(X˜
T
W˜ )Z
(13)
where Z = X˜γ˜ + W˜−1(Y − p˜) is the logistic pseudo vari-
able and is recognized as a better approximation to X˜γ and
hence η(α,β,x).
In underdetermined or nearly singular problems, regulariza-
tion should be applied to tackle the singularity problem of the
matrix X˜TW˜ X˜ in (12) by adding to it a small matrix λR. This
gives
(X˜
T
W˜ X˜ + λR)γ ≈ X˜T (Y − p˜+ W˜ X˜γ˜) (14)
where λ is the positive regularization parameter and R is a di-
agonal matrix with R(0, 0) = 0 and R(j, j) = 1, j = 1, . . . , J .
Equation (14) can be repeatedly used to refine the approxi-
mation γ˜ obtained in the previous iteration, which constitutes
the desired IRWLS algorithm with regularization. In [21], the
regularization parameter is chosen by the Bayesian information
criterion. Whereas in this work, CV is used to fine-tune this
parameter from the training data.
Though regularization reduces the estimation variance and
hence gives a good estimator when X˜TW˜ X˜ is ill-conditioned,
it is also biased. To improve upon the regression vector γ =
[α βT ]
T
, it is suggested in [21] to apply PLS fit of X˜γ to Zˆ
obtained in the previous step
Zˆ = X˜γˆ + W˜
−1
(Y − p(γˆ)) (15)
where γˆ = [αˆ, βˆ
T
]
T
, W˜
−1
and p(γˆ) = [p1(γˆ), . . . , pN ′(γˆ)]T
are computed using the results of the penalized LR above. This
is because, as suggested in (13), Z ≈ X˜γ, where γ is the true
regression vector. An important advantage of using the pseudo
variable Zˆ is that it combines the PLS dimension-reduction
step with the previous ridge regularization step. The former
removes noise in less important dimensions by projecting Zˆ
onto a low dimensional subspace spanned by the principal
components (PCs) and hence de-noises Zˆ through thresholding
the unimportant components. More precisely, Zˆ is written as
Zˆ = X˜γ +E′ (16)
where E′ is the error which is assumed to be normal distributed.
In the PLS, X˜ and Zˆ are related to some latent variables Γ =
[t(1), . . . , t(M)] and Γ˜ = [˜t(1), . . . , t˜(M)] or the PC directions.
We are not concerned about the covariance of X˜ and the
covariance of Zˆ themselves, but the cross-variance between X˜
and Zˆ, i.e.,X˜T Zˆ. More precisely, we use two different bases Γ
and Γ˜ to, respectively, decompose X˜ and Zˆ as follows:
X˜ =
M∑
m=1
t(m)p(m)T +E = ΓP T +E (17)
Zˆ =
M∑
m=1
t˜
(m)
c(m)T + F = Γ˜CT + F (18)
where Γ = [t(1), . . . ., t(M)]T , P = [p(1), . . . .,p(M)]T , t(m) is
an (N × 1) vector, p(m) is an (J × 1) vector, E is the residual
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of X˜ , and M is the number of chosen PCs. Similarly, F is
the residual of Zˆ and C = [c(1), . . . , c(M)]. Γ and Γ˜ are also
called the score matrices containing the directions of the PCs,
while the matrices P and C are called the loadings of the PCs.
In [21], M is chosen by minimizing the misclassification
error in the CV. Note, if t(m) = p(m), we have the conventional
PC analysis of X˜ . However, such an expansion will not be
able to explain Zˆ effectively at the same time and may lead
to inferior performance.
In PLS, t(m) and t˜(m) are determined successively from the
data. At the m iteration, we find vectors ω(m) and q(m) so that
the vectors t(m) and u(m) below are maximal correlated
t(m) = X(m)ω(m), u(m) = Z(m)q(m) (19)
where X(m+1) = X(m) − t(m)p(m)T and Z(m+1) = Z(m) −
t(m)c(m)T are, respectively, the data matrix and observed vec-
tor after removing the contributions form previous iteration. At
the first iteration, X(1) = X˜ and Z(1) = Zˆ. Our goal then is
to determine ω(m) and q(m). If ω(m) and q(m) have unit norm,
the problem can be written as
max t(m)Tu(m), ‖ω(m)‖22 = 1, ‖q(m)‖
2
2 = 1. (20)
Using the Lagrange multiplier method, ω(m) and q(m) can be
solved as an eigenvalue problem, as described in Appendix B.
The final regression vector γPLS , which is defined similarly as
in (11), is obtained as
γPLS = Φ˜(P
T Φ˜)+CT (21)
where Φ˜ = [ω(1), . . . ,ω(M)], p(m) = (X(m)TW˜ t(m))/
(t(m)T t(m)), P = [p(1), . . . .,p(M)]
T
, c(m) = Z(m)TW˜ t(m)/
(t(m)T t(m)), C = [c(1), . . . , c(M)] and (.)+ denotes the
pseudo inverse operator. For notation convenience, we drop
the subscript and consider γ as the final regression vector in
subsequent sections.
If the data is centered, then the intercept is equal to zero, and
one can work only with the regression vector β. Alternatively,
one can ignore the intercept term α and work with β only. α
can then be computed as
α = X
T
W˜1N ′ − (ZTW˜1N ′)Tβ. (22)
The predicted conditional class probability for the testing data
matrix XTEST with NTEST samples is given by
pˆ = h(ηˆ) (23)
where ηˆ = α1NTEST +XTESTβ. Here, a two-nested CV [20]
may be preferred over the single-loop CV used in [21] be-
cause using the same CV loop for both parameter tuning and
performance evaluation may introduce overfitting. Moreover,
if a subset of genes is required, then direct truncation from
the whole gene sets according to say the squared magnitude
of βj may be undesirable. A better approach is to employ
the wrapper-based approach where the classifier should be
evaluated for the given gene set only. However, testing all such
combinations will be computationally prohibitive, and hence
RFE has to be employed.
B. Recursive Feature Elimination With Brier Error Measure
The use of RFE with support vector machine for efficient
feature selection was first proposed in [15]. Motivated by the
effectiveness of RFE, we now extend the RPLS algorithm to
include RFE. In RFE, feature selection is performed by elimi-
nating variables that contribute least to the classifier recursively
according to certain performance criterion until a minimum
gene number is obtained as in many greedy classifiers or a
minimum acceptable classifier performance is achieved.
More specifically, in [15], each variable in the regression
vector β obtained in (21) corresponds to the jth gene, and
the regression coefficients β′js are ranked in descending order
of their squared magnitudes. The intercept obtained in (22) is
ignored because it does not correspond to any of the genes.
Then, the irrelevant genes are eliminated at each iterations. Let
q = 1, 2, . . . , Q denotes the number or index of iterations with
the initial gene index set at the qth iteration given by S(q−1)
having J (q−1) elements. A classifier is then designed using the
gene set S(q−1). By ranking the resulting regression coefficients
according to their magnitudes and retaining only s(q) fraction
of the original gene sets in S(q−1), we obtain the new reduced
gene set S(q) at the qth iteration as follows:
S(q) =
{
j ∈ S(q−1) : β2j is the first
⌈
s(q)J (q−1)
⌉
largest genes amount all J (q−1) genes in S(q−1)
}
. (24)
S(q) is usually initialized to include all the genes in the first
iteration, i.e., S(0) = {1 ≤ j ≤ J}, where J is the total number
of genes of the given samples. The parameter s(q) is called the
step size for variable selection at the qth iteration. In [15], a
fixed step size s(q) = 1/2 is chosen, and half of the genes will
be eliminated. The number of genes retained is
J (q) = s(q)J (q−1). (25)
Hence, the total number of genes retained when the RFE
algorithm terminates is J (Q) = s(1)s(2) . . . s(Q−1)s(Q)J . Since
0 < s(q) < 1, the number of retained genes are usually much
smaller than the original number of genes, i.e., J (Q)  J .
The classification accuracy at each iteration is used as the
performance criterion for various gene subsets generated. The
RFE continues to eliminate half of the genes and terminates
when only one gene is left or no genes can be further eliminated.
The subset with the best classification accuracy among all the
gene sets is chosen. A major limitation of this approach is that
the number of genes retained is always a power of 2, which is
independent of the performance of the classifiers. Hence, the
sampling around the optimal gene number may be limited, and
either some irrelevant genes are retained or some relevant genes
are eliminated.
Unlike [15], we adopt a variable step size which adapts to the
performance of the classifiers in our proposed approach. More
precisely, at each iteration, the RPLS algorithm is invoked on
Y and Xsub, where Xsub is the standardized gene expression
matrix that contains only the selected gene indices given by
S(q). An inner CV is employed to determine the required
regularization for the given gene set. Then, the regression vector
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Fig. 1. Decision network diagram for the recursive feature elimination (RFE).
β is obtained and sorted as in (24). Afterwards, the estimated
performance measure for the qth iteration, denoted by BS(q), is
obtained from the RPLS-based classifier. Here, the performance
measure we employ is the BS [27], which will be discussed
later. If the current estimated BS,BS(q), is smaller, the step
size for the next iteration is halved
s(q+1) =
(
1
2
)
s(q) if BS(q) < BS(q−1) (26)
so that the number of genes eliminated is doubled to speed
up the elimination process. Otherwise, the same iteration is
repeated, except that the step size is increased to s(q) = 1−
(1− s(q))/2 so that the fraction of genes to be eliminated is
reduced to increase the sampling in search of a better gene set.
Fig. 1 shows the decision network diagram of the proposed RFE
approach.
The proposed RPLS-RFE algorithm continues until only one
gene is left or no gene can be further eliminated. The concept
of BS, which is a soft decision metric, is adopted in this study.
Unlike the hard decision as in the conventional misclassification
error, it is less prone to thresholding effect and provides more
precise information to evaluate the reliability of the prediction
model. In digital communications applications, it has been
shown that using soft decision metrics usually leads to better
performance than hard decision metrics. A classical example
is the Viterbi decoder [28] with soft decision output. In our
proposed RPLS-RFE algorithm, the BS is expressed in terms
of the conditional class probability estimate as follows:
BS =
NTEST∑
i=1
(
y(i) − h
(
α+ xT(i)β
))2
(27)
where y(i) is the ith observation of the testing set
Y TEST_INT = [y(1), y(2), . . . , y(NTEST )]
T
, x(i) is the ith
sample of the testing samples XTEST_INT = [x(1),x(2), . . . ,
x(NTEST )]
T
, NTEST is the total number of samples in the
testing set, α is the intercept in (22), β is the regression vector
in (21), and h(η) is the logistic function in (8). For notation
convenience, we have dropped the dependency of BS on the
regression vector β.
In general model selection problem using stepwise linear
regression techniques such as the RFE, the best model can be
obtained by selecting the set of variables with some appropriate
error measures such as minimum mean squared error [29].
Similar idea applies to the proposed approach, where adding
irrelevant genes to or removing relevant genes from the retained
gene subset would increase the BS in (27). Therefore, we expect
that the resultant BS attains its minimum value when the best
model is selected. Next, the details of the two-nested CV for
parameter and model selection will be described.
C. Two-Nested Cross Validation
CV is a technique for assessing how the results of a statistical
analysis will generalize to an independent data set. It is widely
used to estimate the practical performance of a model for
prediction, classification, and related applications. It is usually
divided into several rounds, and each of them partitions the
sample data into complementary subsets, performing the anal-
ysis on one subset, called the training set, and evaluating the
performance of the analysis on the other, called the testing set.
To reduce statistical variability, multiple rounds of CV are per-
formed using different partitions, and the validation results or
performance are averaged over all rounds. CV can also be used
in parameter tuning by selecting the best parameters from a
given set. This is widely used in determining the regularization
parameters in ridge or other regression techniques. In repeated
random subsampling, the partitions are randomly chosen.
In K − fold CV, the original sample is randomly partitioned
into K subsamples. Of the K subsamples, a single subsample
is retained as the validation data for testing the model, and the
remaining K − 1 subsamples are used as training data. The CV
process is then repeated K times (the folds), with each of the K
subsamples used exactly once as the testing data. The K results
from the folds are then averaged, or otherwise combined, to
produce the estimated performance. Its advantage over repeated
random subsampling is that all observations are used for both
training and testing, and each observation is used for validation
exactly once. When K is equal to N , the total number of
samples, it is referred to as the leave-one-out CV (LOOCV).
However, it is usually very expensive from a computational
point of view because of the large number of training processes
involved. Both the 10− fold CV and the LOOCV are widely
used in microarray studies.
The two-nested CV procedure adopted in this work is a
recent tool that has received considerable attention in the
bioinformatics community [20], [23], [30], [31]. In classifica-
tion, an important advantage of the nested CV procedure is
that it overcomes the limitation of the optimistic and selec-
tion biases [20], [23] often found in using conventional CV
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procedure in joint parameter tuning and performance evalua-
tion. In two-nested CV, an internal CV is used for parameter
tuning, while the external CV is used for evaluating the classi-
fication performance.
In the proposed RPLS-RFE method with two-nested CV, the
external CV is used to generate different subsamples so that dif-
ferent gene subsets can be found and the variability/predicting
power can be studied, while the inner CV will be used to de-
termine the regularization parameter λ in (14) and the number
of PCs M in (17). Moreover, we apply stratification on the
CV so that each subsample has an equal proportion of subjects
belonging to different classes, e.g., 60% cancer and 40% normal
samples. This procedure helps to reduce bias due to unbalanced
proportion of samples. This is different from the RPLS method
in [21], which uses a single-loop CV procedure for parameter
tuning and evaluating the classification performance. While in
[15], the single-loop CV procedure is used for feature selection,
parameter tuning, and performance evaluation of classification.
More specifically, consider a K − fold CV procedure,
where the observation Y and gene expression matrix X is par-
titioned into K subsamples. At the kth loop, k = 1, 2, . . . ,K,
the testing set is formed by the kth subsample (Y k,Xk) such
that
Y TEST =Y k =
[
yka+1, yka+2, . . . , y(k+1)a
]T (28)
XTEST =Xk =
[
xka+1,xka+2, . . . ,x(k+1)a
]T (29)
where a = [N/K], [N/K] is the integer part of N/K, and N
is the total number of samples. If N is not divisible by K and
the reminder is A, the remaining samples will be distributed
among the firstA subsamples so that they have one extra sample
more than the remaining K −A subsamples. The training
set (Y TRAIN ,XTRAIN ) is formed by the remaining K − 1
subsamples as
Y TRAIN =
[
Y T1 ,Y
T
2 , . . . ,Y
T
k−1,Y
T
k+1, . . . ,Y
T
K
]T (30)
XTRAIN =
[
XT1 ,X
T
2 , . . . ,X
T
k−1,X
T
k+1, . . . ,X
T
K
]T
. (31)
Centering in (1) and standardization in (2) are invoked on
XTRAIN and XTEST using the mean value and standard
deviation of XTRAIN to obtain XTRAIN and XTEST , re-
spectively. The algorithm to be evaluated is then invoked using
the training set for learning and the testing set for evaluating its
performance.
For the two-nested CV adopted in our proposed approach, the
samples are first partitioned into K subsamples. At the external
CV loop, the training set (Y TRAIN_EXT ,XTRAIN_EXT )
and testing set (Y TEST_EXT ,XTEST_EXT ) are the same
as those in (28)–(31). The external K-fold CV loop is used to
evaluate the performance of the RPLS-RFE algorithm and to
obtain different selected gene subsets from the subsamples. In
the internal K − 1 fold CV loop, the training set is given by
Y TRAIN_INT =
[
Y T1,Y
T
2, . . . ,Y
T
k−2,Y
T
k+1, . . . ,Y
T
K
]T (32)
XTRAIN_INT =
[
XT1,X
T
2, . . . ,X
T
k−2,X
T
k+1, . . . ,X
T
K
]T (33)
so that both the (k − 1)th and the kth subsample are omitted
from the training set. The testing set is given by
Y TEST_INT = Y k−1, XTEST_INT = Xk−1. (34)
Centering and standardization are then performed similar to
those for the external training and testing sets. The internal CV
loops are then used for parameter tuning of the RPLS-RFE al-
gorithm. The regularization parameter λ in (14) and the number
of PCs M in (17) are chosen to minimize the estimated error
returned by the RPLS-RFE algorithm in the internal CV loops.
λ and M are confined to a set of possible values and a 2-D
grid search is used to choose the best parameters that yield the
minimum error measure. This offers some protection against
local minima [32]. Moreover, to speed up the process, we
adopted an iterative grid search approach that is similar to [33].
Now, we discuss the error measure used for parameter tuning.
Conventionally, the misclassification error and the area under
the receiver operation characteristic curve are used as error
measures for parameter tuning in many classification algo-
rithms. These measures are based on hard decision metrics, i.e.,
the metric is discrete, such as true positive (TP), false positive
(FP), and so on. On the other hand, in the proposed approach,
we adopt the concept of BS [27], which is a soft decision metric.
As mentioned earlier, it provides more precise information to
ensure the reliability of the prediction model.
D. Occurrence Probability Measure for Gene Ranking
As mentioned earlier, the high dimensionality, large biologi-
cal variability, and small number of samples in gene microarray
analysis create extremely large statistical variations in conven-
tional regression techniques and hence complicated the detailed
analysis of gene microarray data and related biological data.
Therefore, conventional approaches employ gene selection and
work with very few gene sets to boost the performance of
the classifiers. However, this approach sacrifices the ability to
identify related genes in the GRNs as studied in this paper,
through which the GRNs can be inferred from public domain
gene network database. Another major difficulty in identifying
these genes is that, after CV, many methods generate gene sets
with very large variability, and hence it is difficult to give a
reliable ranking of the genes.
In our approach, two-nested CV using RPLS-RFE with
Brier measure helps us to reduce significantly the statistical
and biological variations. If the gene sets are stable, then the
relevant genes should in principle appear in different external
CV rounds. Hence, it is natural to employ the OP of a given
gene in the final gene set of different CV rounds as a measure
of its importance.
More specifically, consider a chosen subset of gene indices
S(Q) estimated from a subsample in CV defined in (39) to (42).
We are given K subsamples, and the set of gene indices chosen
for all subsamples is S = {S(Q)1 , S(Q)2 , . . . , S(Q)K }, where S(Q)k
is the chosen subset of gene indices obtained from the kth
subsample. In the subsamples, only J (Q) genes are retained by
the RPLS-RFE algorithm. Also, J (Q)  J and hence most of
the irrelevant genes are omitted from subsamples. The proposed
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TABLE III
CANCER DATASETS
OP measure for ranking the gene indices across different
subsamples is given by
OP (j) =
kj
K
(35)
where kj is the number of occurrence of the jth gene among
K subsamples. Since only J (Q) genes are retained in the
subsamples, the OP of the irrelevant genes eliminated by RFE
will vanish since kj = 0. As this measure extracts a group of
genes that bear high consistency across “different subsamples,”
they are more likely to contribute to the biological disease or
event under study. Moreover, such consistency will also help
us to discover the interaction between important genes that
may originate from different regulatory structures. By tracing
the top ranked genes back to their gene pathways in public
domain gene network database, there is a high hope of finding
out the gene pathways or GRNs involved in that disease. From
the experimental results to be presented below, we show that
a number of relevant genes and GRNs can be preliminarily
identified in such a manner and most of them are consistent
with the findings in biological experiments.
IV. RESULTS
In this section, we consider the preliminary identification
of cancer-related genes and their associated GRNs. Moreover,
since classification performance is a conventional criterion for
assessing the performance of an algorithm, we also compare
the classification performance of our proposed RPLS-RFE al-
gorithm with other conventional approaches. We consider three
real cancer data sets, namely leukemia [9], colon [24], prostate
[25], and they are obtained from the Kent Ridge Biomedi-
cal Data Set Repository (http://datam.i2r.a-star.edu.sg/datasets/
krbd/). A brief description of the data sets is summarized in
Table III.
A. Classification Results
As an illustration, we compare the classification performance
of our proposed approach (RPLS-RFE) and other conventional
approaches reported in [30]. In the evaluation of classification
performance, we adopted the two-nested CV procedure, which
is a recent tool receiving considerable attention in the bioinfor-
matics society because it overcomes the limitation of selection
and optimistic bias [20], [23] found in the conventional CV
procedure, say in [15] and [21]. Since all algorithms should be
TABLE IV
CLASSIFICATION ACCURACY OF DIFFERENT APPROACHES FOR
LEUKEMIA, COLON AND PROSTATE DATA
evaluated using the same CV procedure, we do not attempt to
compare the results with [15] and [21] for fair comparison.
There are two commonly used CV procedures, namely the
LOOCV and the 10− fold CV. For fair comparison, we
adopted a two-nested 10− fold CV procedure described in
[30]. The mean classification accuracy is obtained from 100
repeated runs of the two-nested 10− fold procedure.1 The
performance of all algorithms is assessed by the classification
accuracy
Accuracy =
(TP + TN)
(TP + TN + FP + FN)
(36)
where TP is the number of TPs, FN is the number of false
negatives, TN is the number of true negatives, and FP is the
number of FPs. Table IV shows the classification results for the
three data sets. The results from other approaches are directly
quoted from [30].
In order to study the effect of RFE and BS on RPLS, three
different configurations of the proposed approach are consid-
ered using two-nested CV:
A. RPLS+RFE+BS+two-nested-CV: RFE is enabled, and
only the subset of genes chosen by RFE is used for
classification.
B. RPLS+BS+two-nested-CV: RFE is disabled, and all vari-
ables are retained for classification.
C. RPLS+two-nested-CV: RFE is disabled and all vari-
ables are retained for classification. Unlike the other two
1For a 10− fold CV, there are CN10 ways of generating the subsamples,
where CN10 denotes the binomial coefficient. However, since CN10 could be
very large, it is a common practice as in [30], [34]–[36] to examine only part
of the combinations. More precisely, combinations of different samples are
chosen randomly to form partitions (subsamples), and for each combination, the
two-nested 10− fold CV procedure is invoked independently. In this section,
100 different combinations are considered for fair comparison with different
classifiers reported in [30].
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Fig. 2. Average computation time (s) of RPLS with and without BS measure
versus the number of genes (variables).
approaches, the conventional misclassification error for
parameter tuning is employed.
From Table IV, we can see that the incorporation of RFE
in configuration A slightly degrades the overall classification
accuracy. This is reasonable since configurations B and C use
all the genes in the final classifiers. However, this may not be
desirable in practice since the entire gene expressions have to be
recorded, which greatly increases the practical implementation
cost. If the gene set is simply truncated, then its results are
usually inferior to the one using RFE, as will be shown later.
Comparing configurations B and C, we can see that the
incorporation of BS in B gives lower variance in classification
accuracy for the three data sets. This suggests that the contin-
uous nature of the BS provides more precise information and
is less prone to the quantizing effect of the misclassification
error. Hence, it leads to higher reliability in model selection and
reduces the variance of the prediction model. Also, we can see
that our proposed RPLS-RFE approach generally offers highly
comparable classification performance as compared with other
conventional approaches.
To assess the complexity of the RPLS with and without Brier
error measures, Fig. 2 shows the average computation times for
the two algorithms versus the number of genes (variables). In
RFE, the genes are progressively eliminated as in (26) to arrive
at the desired gene sets having the best classification accuracy
among all the gene sets tested. Generally, it takes an average of
4.0, 4.5, and 4.7 RFE iterations in colon, leukemia, and prostate
data set to reduce the number of genes to around 100. Since the
RFE can eliminate a large proportion of the irrelevant genes
within a small number of iterations, the arithmetic complexity
is significantly smaller than that of an exhaustive search of
all possible subsets, i.e., testing the whole curve in Fig. 1.
Meanwhile, the computation time is only around 1 s when
the number of genes is smaller than 100. Although it takes
another 16, 19, and 20 RFE iterations for colon, leukemia, and
prostate, respectively, to terminate, the required computation
time is only around 16–20 s. Most of the computation time
originates from the first five RFE iterations which require much
higher complexity.
TABLE V
GENES REGULATORY NETWORK IDENTIFIED FROM TOP 50 GENES
SELECTED BY PROPOSED RPLS-RFE ALGORITHM IN LEUKEMIA
Nevertheless, we remark that the main focus in this paper
is on the preliminary identification of cancer-related genes and
associated GRNs, which has not been reported using such kind
of technique. We now present these novel findings.
B. Gene and Regulatory Network Identification
Unlike the two-nested 10− fold CV used in previous sec-
tion, we adopted a two-nested LOOCV procedure in this sec-
tion. Since there is one (i.e., CNN = 1) combination of forming
the CV partitions for the LOOCV, only one complete run is
needed. An advantage is that it is able to obtain larger training
sets among all CV procedures. This property is particularly
useful for small samples because larger training sets provide
more information for training the algorithm. The training set
for the LOOCV has N − 1 samples, while the training set for
tenfold CV has 0.9N samples. For N > 10, N − 1 > 0.9N .
Therefore, LOOCV provides a larger training set than the
tenfold CV when N > 10.
Both the GR and OP of our proposed approach are computed
according to the chosen subset of genes using the RFE as
described in Section III-B. Unlike our proposed approach, the
GR of the conventional approaches considered is found by
invoking the algorithms on the whole data set, which may
involve overfitting problem. Meanwhile, the OP is found by
invoking the algorithms on different CV subsamples generated
by two-nested LOOCV. However, since the number of genes
retained cannot be computed by the algorithms, they are usually
chosen by user experience [17], [37]. As an illustration, the
number of genes retained is chosen as 50 for these algorithms.
For leukemia, we checked the Kyoto Encyclopedia of Genes
and Genomes (KEGG) database [38] and identified three GRNs
from the top 50 ranked genes obtained by our proposed
RPLS-RFE algorithm as summarized in Table V. In particular,
the functionalities of the two more important pathways are
summarized below.
1) Ribosome pathway [39]: The Ribosome pathway is re-
sponsible for the synthesis of ribosomes, which are
made to construct different kinds of proteins of the
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Fig. 3. Ribosome pathway (KEGG) [39] and its associated genes. (reproduced through the courtesy of the KEGG database [38]).
ribosomal subunits [40] in human cells, and contributes in
ribosome biogenesis. Mutation of ribosome biogenesis-
related genes will cause increasing susceptibility to can-
cer such as leukemia [41].
2) Pathways in Cancers [42]: Different cancer may take
a different pathway to become malignant, and the dif-
ference is highly variable. However, the biological end-
points ultimately reached should be shared in common.
Pathways in Cancer belong to the common pathway
that different type of cancers share. The pathway brings
upon alternations (known as hallmark capabilities) in cell
physiology that collectively dictates malignant growth.2
We have also identified some cancer-related genes among the
top 50 ranking genes of our proposed RPLS-RFE algorithm.
Table VI shows the comparison of GR and OP between our
proposed RPLS-RFE and other conventional algorithms on the
cancer-related genes.
1) Metallopanstimulin 1 (HG3214-HT3391_at) is found to
be a marker gene of various cancer [43]. The MPS-1
gene encodes Metallopanstimulin which is generally in-
volved in growth factor induced response, carcinogenic
ribotoxic, and the aging process [44]. Growth factors and
growth factor receptors are responsible for the activa-
tion of signal transduction and the regulation of tran-
scription. Damage to this type of genes may result in
oncogenesis [44].
2The pathway diagrams for Ribosome [39] and Cancer pathway [42] are
shown in Figs. 3 and 4, respectively, and they can be found in KEGG database
[38]. Other pathway diagrams can also be found for colon and prostate data set
considered later, but they are omitted to save space.
2) Wilm’S Tumor-Related Protein (HG3549-HT3751_at)
[45] is a tumor suppressor gene. The expression of the
gene suppresses the development of leukemia tumor
cells [46].
3) Laminin receptor [47] (M14199_s_at) encodes the
Laminin receptor, and is a biomarker of malignant trans-
formation. Laminins are shown to be implicated in
many biological processes such as cell adhesion, dif-
ferentiation, migration, signaling, neurite outgrowth, and
metastasis.
4) Glyceraldehyde-3-phosphate dehydrogenase
(X01677_f_at) [48], is found to be involved in the
regulation of apoptosis, known as programmed cell
death, of leukemia cells.
5) Fibronectin 1 (HG3044-HT3742_s_at) [49]: Fibronectin
is a matrix glycoprotein where the extracellular matrix
influences various cellular functions such as adhesion,
migration, survival, and differentiation. It was suggested
to be involved in stimulating tumor cell proliferation.
6) PTMA Prothymosin alpha (M26708_s_at) [50] is found
to be involved in mediating immune functions by confer-
ring resistance to certain opportunistic infections It is also
found to be correlated to the proliferation of leukemia
cells.
Overall, we can see that the pathways and genes identified
are closely related to cancer and leukemia, as reported in
the biology literature cited. Since the procedure of GR has
been designed to reduce as much as possible the bias and
variance using two-nested CV, it leads us to believe that the
findings are intimately related to the underlying disease, but not
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Fig. 4. ECM sub-branch of the Cancer pathway (KEGG) [42] and its associated genes (reproduced through the courtesy of the KEGG database [38]).
from statistical variations. Also, we note that considerable top
ranked genes are associated with the ribosome and metabolic
pathways. About half of the top 50 genes in our algorithm
are associated with the pathways discovered. This suggests
that leukemia is intimately associated with these networks. The
other genes in the top 50 ranked gene list may be associated
with these networks or leukemia indirectly, while possesses
very high discrimination power at the same time. A possible
explanation of this observation is that the strength of gene
expressions for different genes may vary considerably, and
therefore those intimately associated with a particular disease
may have a lower gene expression than other related genes
not in the main pathways [13]. Nevertheless, by exploring the
consistent correlation between these genes through RPLS and
OP , the proposed method appears to be able to detect those
genes associated with the key pathways than those focusing
entirely on a small gene list for classification purpose. In terms
of classification, all the top rank genes are useful as they
depicted a very high classification rate as shown in Table IV.
Also, the biological variations, limited number of samples, and
high dimensionality also introduce variance in their rankings.
To further substantiate the statistical significance of the ex-
tracted gene sets, we test the extracted genes against a model
assuming that they are solely picked by random. Results show
that 43 extracted genes using the proposed OP criterion are
found to be significant at 5% significance level, which is similar
in spirit to the commonly used p-value. Similar findings are
obtained for the colon [24] and prostate [25] data sets, interested
readers are referred to the supplementary material in [51].
As all these data sets give similar conclusions, it leads us
to believe that the proposed method is capable of extracting
preliminary meaningful GRNs and gene information from the
gene microarray data of the respective cancer diseases studied.
Of course, more studies are needed to quantify how the sample
size affects the variance of the method. Studies with larger
sample size are thus highly desirable in the future.
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TABLE VI
RANKING AND OCCURRENCE PROBABILITY OF CANCER-RELATED
GENES OF DIFFERENT APPROACHES FOR LEUKEMIA
In closing, we remark that the proposed method is appli-
cable to other diseases and other forms of gene data, which
potentially can shorten significantly the time to identify pre-
liminarily critical genes and pathways associated with known
or new diseases from such high throughout biological data.
The shortlisted genes can then be further investigated through
biological experiments.
V. CONCLUSION
A new gene identification approach based on RPLS with RFE
and novel Brier and OP measures has been presented. The esti-
mation variance is improved by incorporating RPLS with RFE
and the Brier error measure using a two-nested CV. Second,
novel Brier and OP-based measures are utilized to rank genes
across CV subsamples and detect different GRNs from corre-
lated genes, which consistently appear in the ranking list. In the
analysis of three publicly available data sets including leukemia
[9], colon [24], and prostate [25], experimental results showed
that cancer-related genes and their associated GRNs can be
preliminarily identified, while the classification performance is
highly comparable with other conventional approaches. These
findings suggest that the proposed approach may serve as a use-
ful tool for preliminary identification of biological significant
genes and their associated GRNs associated with a particular
disease for further biological studies using gene microarray or
other similar data.
APPENDIX A
DERIVATION OF LOGISTIC REGRESSION
In this section, the solution of maximizing the log-likelihood∑N ′
i=1[yi ln pi(α,β) + (1− yi) ln(1− pi(α,β))] in (10) is de-
rived. It can be determined by setting the partial derivative of
the log likelihood to zero. This yields [52]:
∂ ln(L)
∂α
=1TN ′ (Y − p(α,β)) = 0 (A1)
∂ ln(L)
∂β
=X
T
TRAIN (Y − p(α,β)) = 0 (A2)
where p(α,β) = [p1(α,β), . . . , pN ′(α,β)]T . As p(α,β) is
nonlinear in α and β, we use a first-order Taylor series as an
approximation to p(α,β) as follows:
pi(α,β) ≈ pi(α˜, β˜) + ∂pi
∂α
∣∣∣∣
α=α˜
(α− α˜)
+
J∑
j=1
∂pi
∂βj
∣∣∣∣
βj=β˜j
(βj − β˜j) (A3)
where α˜ and β˜ are approximate solution, say obtained in
previous iteration
∂pi
∂α
= p˜i(1− p˜i), (A4)
∂pi
∂βj
= p˜i(1− p˜i)xij (A5)
and p˜i = pi(α˜, β˜). To simplify notation, we further define
X˜ = [1N ′ XTRAIN ] and γ = [α βT ]
T
. (A6)
Combining (A4) and (A5), the desired solution satisfies
(X˜
T
W˜ X˜)γ ≈ X˜T (Y − p˜+ W˜ X˜γ˜) (A7)
where W˜ = diag{w˜1, w˜2 . . . .w˜N ′}, w˜i = p˜i(1− p˜i), and
p˜i = pi(γ˜) = pi(α˜, β˜). By solving (A6) and using the solution
as the new estimate γ˜ = [α˜ β˜T ]
T
repeatedly, one obtains the
IRWLS algorithm for solving the regression coefficients.
APPENDIX B
DERIVATION OF PARTIAL LEAST SQUARES
In this section, the details of solving the optimization
max{t(m)Tu(m), ‖ω(m)‖22 = 1, ‖q(m)‖
2
2 = 1} in (25) is de-
rived. By means of the Lagrange multiplier method, ω(m) and
q(m) can be solved as an eigenvalue problem. To this end, we
form the Lagrangian function as
L = t(m)Tu(m) − λ1
(
‖ω(m)‖22 − 1
)
− λ2
(
‖q(m)‖22 − 1
)
(B1)
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where λ1 and λ2 are the Lagrange multipliers. The optimal
solution is obtained by setting the gradient of L with respect
to ω(m) and q(m) to zero. This yields X(m)TZ(m)q(m) =
2λ
(m)
1 ω
(m) and Z(m)TX(m)ω(m) = 2λ(m)2 q(m). Further
eliminating q(m) gives X(m)TZ(m)Z(m)TX(m)ω(m) =
λ
(m)
1 λ
(m)
2 ω
(m)
. Hence, ω(m) is the eigenvector of C˜(m) =
C(m)xz C
(m)
zx = X
(m)TZ(m)Z(m)TX(m) and
q(m) =
Z(m)TX(m)ω(m)√
ω(m)TX(m)TZ(m)Z(m)TX(m)ω(m)
=
Z(m)TX(m)ω(m)√
ω(m)T C˜
(m)
ω(m)
. (B2)
Let X(m)TZ(m)=
∑R
i=1 σ
(m)
i u
(m)
i v
(m)T
i =U
(m)Λ(m)V(m)T
be the singular value decomposition of X(m)TZ(m), where
R is the number of basis of X(m)TZ(m). It can be seen that
ω(m) is the first largest singular vector of X(m)TZ(m) while
q(m) is the right singular vector of X(m)TZ(m) with σ(m)1 =
2λ
(m)
1 . After t(m) is determined from ω(m) using (24), we can
determine p(m) from the rank-one approximation to X(m) as
X(m) = t(m)p(m)T +E(m). (B3)
If E(m) is normal distributed, then p(m) can be determined as
min
p(m)
∥∥∥∥W˜
1
2X(m) − W˜
1
2 t(m)p(m)T
∥∥∥∥
2
2
(B4)
and its solution is p(m)=(X(m)TW˜ t(m))/(t(m)T t(m)). Note,
from (13), we can see that Z is weighted by X˜TW˜ and there-
fore both Zˆ and X˜ should be weighted by W˜ 1/2 where W˜ is
the weight matrix of LR given in (12). Since X(m)TW˜ t(m) =
(W˜
1/2
X˜−W˜ 1/2∑m−1i=1 tipTi )TW˜ 1/2t(m)=X˜TW˜ t(m), we
haveP T=(TW˜D−1)TX˜ . Similarly,c(m) can be determined as
min
c(m)
∥∥∥∥W˜
1
2Z(m) − W˜
1
2 t(m)c(m)T
∥∥∥∥
2
2
(B5)
and its solution is c(m)=Z(m)TW˜ t(m)/(t(m)T t(m)). Since
Z(m)TW˜ t(m)=(W˜
1/2
Zˆ−W˜ 1/2∑m−1i=1 ticTi )TW˜ 1/2t(m)=
Zˆ
T
W˜ t(m), we have CT = (ΓW˜D−1)T Zˆ where Γ = [t(1),
. . . , t(M)] and M is the number of PC retained. The process can
be repeated by removing the contributions of these components
from X(m) and Z(m) as
X(m+1)=X(m)−t(m)p(m)T , Z(m+1)=Z(m)−t(m)c(m)T .
(B6)
The final regression vector γPLS is obtained as
γPLS = Φ˜(P
T Φ˜)
+
CT , with Φ˜ =
[
ω(1), . . . ,ω(M)
]
. (B7)
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